Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Domchek

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
JAMA|August 21, 2019
Broadening Criteria for BRCA1/2 Evaluation: Placing the USPSTF Recommendation in ContextSusan Domchek, Mark Robson
JAMA Oncology|October 4, 2019
Broad Application of Multigene Panel Testing for Breast Cancer Susceptibility-Pandora's Box Is Opening WiderMark Robson, Susan Domchek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Genetic variants of uncertain significance: flies in the ointmentSusan Domchek, Barbara L Weber
Menopause (New York, N.Y.)|August 10, 2016
Use of systemic hormone therapy in BRCA mutation carriersSusan Domchek, Andrew M Kaunitz
The New England Journal of Medicine|November 2, 2017
Olaparib for Metastatic Germline BRCA-Mutated Breast CancerMark Robson, Carsten Goessl, Susan Domchek
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 18, 2014
Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencingAngela R Bradbury, Linda Patrick-Miller, Susan Domchek
Clinical Breast Cancer|February 3, 2004
Gemcitabine and trastuzumab combinations for patients with metastatic breast cancer overexpressing HER2/neuSteven Stein, Angie DeMichele, Susan Domchek, et al.
Journal of the National Cancer Institute|November 29, 2007
Breast cancer risk among male BRCA1 and BRCA2 mutation carriersYu Chuan Tai, Susan Domchek, Giovanni Parmigiani, et al.
Community Genetics|April 18, 2008
BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancerLisa Kessler, Susan Domchek, Jill Stopfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Reply to R.L. Nussbaum et al and J.S. Dolinsky et alJudith Balmaña, Katherine Nathanson, Kenneth Offit, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
JAMA|August 21, 2019
Broadening Criteria for BRCA1/2 Evaluation: Placing the USPSTF Recommendation in ContextSusan Domchek, Mark Robson
JAMA Oncology|October 4, 2019
Broad Application of Multigene Panel Testing for Breast Cancer Susceptibility-Pandora's Box Is Opening WiderMark Robson, Susan Domchek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Genetic variants of uncertain significance: flies in the ointmentSusan Domchek, Barbara L Weber
Menopause (New York, N.Y.)|August 10, 2016
Use of systemic hormone therapy in BRCA mutation carriersSusan Domchek, Andrew M Kaunitz
The New England Journal of Medicine|November 2, 2017
Olaparib for Metastatic Germline BRCA-Mutated Breast CancerMark Robson, Carsten Goessl, Susan Domchek
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 18, 2014
Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencingAngela R Bradbury, Linda Patrick-Miller, Susan Domchek
Clinical Breast Cancer|February 3, 2004
Gemcitabine and trastuzumab combinations for patients with metastatic breast cancer overexpressing HER2/neuSteven Stein, Angie DeMichele, Susan Domchek, et al.
Journal of the National Cancer Institute|November 29, 2007
Breast cancer risk among male BRCA1 and BRCA2 mutation carriersYu Chuan Tai, Susan Domchek, Giovanni Parmigiani, et al.
Community Genetics|April 18, 2008
BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancerLisa Kessler, Susan Domchek, Jill Stopfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Reply to R.L. Nussbaum et al and J.S. Dolinsky et alJudith Balmaña, Katherine Nathanson, Kenneth Offit, et al.
Pageof 10